NCT04509934

Brief Summary

The purpose of this study was to reveal the effects of connective tissue manipulation (CTM) on pain severity, fatigue, sleep quality, general health status, systemic symptoms, anxiety and depression in women with primary dysmenorrhoea and to determine the effect of treatment time on recovery in a longterm period. Our primary outcome was intensity of menstrual pain. Secondary outcomes were intensity of sleep disturbance, fatigue, depression and anxiety status, general health and premenstrual symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2020

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 12, 2020

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

1.7 years

First QC Date

July 14, 2020

Last Update Submit

August 11, 2020

Conditions

Keywords

primary dysmenorrheapainwomenconnective tissue manipulationlongterm follow up

Outcome Measures

Primary Outcomes (4)

  • Visual Analogue Scale

    Intensity of menstrual pain was evaluated by a 0- to 10-cm Visual Analog Scale (VAS), where "0" point indicated "no pain" and "10" indicated "unbearable pain."

    baseline (first assessment) and 3th, 6th and 12th months after treatment

  • Visual Analogue Scale

    Intensity of menstrual pain was evaluated by a 0- to 10-cm Visual Analog Scale (VAS), where "0" point indicated "no pain" and "10" indicated "unbearable pain."

    3th month after treatment

  • Visual Analogue Scale

    Intensity of menstrual pain was evaluated by a 0- to 10-cm Visual Analog Scale (VAS), where "0" point indicated "no pain" and "10" indicated "unbearable pain."

    6th month after treatment

  • Visual Analogue Scale

    Intensity of menstrual pain was evaluated by a 0- to 10-cm Visual Analog Scale (VAS), where "0" point indicated "no pain" and "10" indicated "unbearable pain."

    12th month after treatment

Secondary Outcomes (24)

  • Visual Analogue Scale

    baseline (first assessment)

  • Visual Analogue Scale

    3th month after treatment

  • Visual Analogue Scale

    6th month after treatment

  • Visual Analogue Scale

    12th month after treatment

  • Visual Analogue Scale

    baseline (first assessment)

  • +19 more secondary outcomes

Study Arms (2)

Group 1

ACTIVE COMPARATOR

Connective Tissue Manipulation was performed to participants in Group 1, starting at the end of the menstrual cycle, 5 days a week and for 1 cycle (approximately 3 weeks) until the beginning of the next period.

Other: Connective Tissue Manipulation

Group 2

ACTIVE COMPARATOR

In Group 2, Connective Tissue Manipulation was started with the completion of menstrual cycle performed to participants for 5 days a week and until the other menstrual cycles. At the end of the menstrual cycle, it was restarted and a total of 2 cycles were applied until the second menstrual cycle started (approximately 6 weeks).

Other: Connective Tissue Manipulation

Interventions

The position of the patients during treatment sessions was sitting with the hips and knees at 90° flexion and feet supported, arms relaxed on the thighs, back naked and straight, allowing optimal tension of the connective tissue. The CTM procedure consisted of treating 3 sections in the back. These sections were basic (sacral and lumbar regions), lower thoracic (L1 through T7) and anterior pelvic. All sessions were ended with bilateral long strokes to the iliac crest and subcostal regions. The physiotherapist applied strokes bilaterally by her middle finger of the right or left hand to the defined zones of the mentioned sections in the back. The treatment started from the basic section, and progress to other regions was decided according to the vascular reaction of the connective tissue. Each session lasted for 5 to 20 minutes, depending on the extent of the treated area.

Group 1Group 2

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being in a age range 18-30
  • Diagnosed with Primary Dysmenorrhea by a gynecologist
  • Having a regular menstrual cycle (28±7 days)
  • Being nulliparous
  • Having menstrual pain intensity above 5cm according to Visual Analog Scale

You may not qualify if:

  • Having gastrointestinal, urogynecologic, or psychiatric disease, other chronic pain syndromes
  • Having a positive pregnancy test
  • History of pelvic surgery
  • Usage of oral contraceptives or antidepressants for at least 3 months
  • Having irregular menstrual cycles (defined as lasting\<21or\>35 days)
  • Having a history or an ultrasonographic observation of pathological conditions indicating secondary dysmenorrhea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University

Denizli, 20000, Turkey (Türkiye)

Location

Related Publications (1)

  • Yagci N, Senel A, Atalay OT, Akman TC, Can OK. Long-Term Follow-Up Result of Connective Tissue Manipulation in Young Women with Primary Dysmenorrhea: Different Intervention Durations. Reprod Sci. 2023 Jul;30(7):2198-2209. doi: 10.1007/s43032-023-01172-5. Epub 2023 Jan 30.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nesrin Yağcı, PT, Prof

    Pamukkale University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The statistical analyses will be performed by the statistics specialist that does not know anything about the methodology of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant, Sub-investigator, Physiotherapist, MSc

Study Record Dates

First Submitted

July 14, 2020

First Posted

August 12, 2020

Study Start

July 30, 2018

Primary Completion

March 30, 2020

Study Completion

March 30, 2020

Last Updated

August 12, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations